A newly-described immunodeficiency syndrome of neutrophil defects, bone marrow fibrosis, nephromegaly, and life-threatening infections arises from a genetic mutation that impairs movement of proteins within cells, researchers found.
Asking three simple questions of patients with non-inflammatory musculoskeletal pain improved primary care physicians’ ability to predict which patients would still be in pain 6 months later, a… read more.
Should women take calcium and vitamin D supplements after menopause for bone health? Recommendations conflict, and opinions are strong.
Trend toward more cancers and more deaths among heart failure patients. Heart failure patients are surviving more often with the heart condition but they are increasingly more likely… read more.
Spinal injections of steroids, intended to relieve back pain, increased bone fragility in the vertebrae of older patients, a retrospective analysis found.
Heart surgery patients reported persistent pain for at least 4 weeks after the procedure, and that pain appeared to manifest as shortened total sleep time, researchers reported.
Men with chronic pain and opioid-induced androgen deficiency may find some pain relief with testosterone replacement therapy, a small trial suggested.
Study Raises Concerns about Impact on Patient Care and Safety. Residents in anesthesiology training programs have high rates of burnout and depression, reports a survey study in the… read more.
Researchers announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA® (sitagliptin) 100 mg once-daily achieved similar blood… read more.
In recent years, there has been an adjustment in the scientific thinking about the utility of screening men for prostate cancer using prostate-specific antigen (PSA).
by Elizabeth C. Smyth, MB, BCh, MSc, and David Cunningham, MD, FRCP, FMedSci – In 2000, in order to optimise service provision for patients with cancer, 34 “Cancer… read more.
Could cut costs of aftercare – The latest results from the third International Stroke Trial (IST-3) suggest that the drug has the potential to cut costs by reducing… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
